WithdrawnPhase 1

Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks

Stopped: No participants enrolled

0Started 2008-03

Plain-language summary

The purpose of this study is to improve port wine stain therapeutic outcome in response to laser therapy. The researcher want to determine whether the combined use of pulsed dye laser therapy and topical ranibizumab will improve port wine stain therapeutic outcome.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Port Wine Stain suitable for comparison testing * Age \> 18 years of age Exclusion Criteria: * History of photodermatoses or skin cancer * use of known photosensitizing drugs * use of immunosuppressive drugs or systemic steroids * Pregnancy

What they're measuring

Port Wine Stain response to laser treatment

Timeframe: 8 weeks

Trial details

NCT IDNCT00667472

SponsorUniversity of California, Irvine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-11

View on ClinicalTrials.gov More Port-Wine Stain trials